A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)
Clinical trial NCT04261933 · COMPLETED
Trial details
- NCT number
- NCT04261933
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-02-13
- Primary completion
- 2021-05-25
- Enrollment
- 789
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.